Mary Van Beusekom | News Writer | CIDRAP NewsMay 25, 2020The data show the antiviral drug cut recovery time from 15 to 11 days.
Study: Remdesivir benefits some COVID-19 patients
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- During pandemic, ivermectin use rose 10-fold, hydroxychloroquine use doubled, study reveals
- ACIP postponement, shelving of CDC vaccine campaigns stir fears
- US flu still high, COVID low but elevated in some areas, RSV declining, CDC says
- Data suggest Paxlovid doesn’t reduce severe COVID in older, vaccinated adults